Kyriakos P Papadopoulos Selected Research

Non-Hodgkin Lymphoma (Lymphosarcoma)

1/2019	A First-in-Human Study of Novel Cereblon Modulator Avadomide (CC-122) in Advanced Malignancies.
1/2016	A multicenter phase II study of sepantronium bromide (YM155) plus rituximab in patients with relapsed aggressive B-cell Non-Hodgkin lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyriakos P Papadopoulos Research Topics

Disease

68	Neoplasms (Cancer) 04/2024 - 12/2002
11	Fatigue 01/2022 - 06/2012
8	Exanthema (Rash) 10/2020 - 05/2009
7	Multiple Myeloma 01/2019 - 01/2015
6	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 10/2016
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 01/2016
4	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2016
4	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2016
4	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 01/2016
4	Nausea 01/2022 - 03/2014
3	Hypoxia (Hypoxemia) 10/2021 - 11/2008
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2018
3	Febrile Neutropenia 08/2018 - 06/2013
3	Neutropenia 02/2017 - 06/2013
2	Carcinogenesis 11/2023 - 01/2021
2	Disease Progression 11/2023 - 11/2019
2	Diarrhea 01/2022 - 02/2015
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2016
2	Body Weight (Weight, Body) 01/2021 - 01/2018
2	Adenocarcinoma 01/2021 - 11/2020
2	Edema (Dropsy) 10/2020 - 10/2017
2	Lymphoma (Lymphomas) 01/2020 - 06/2015
2	Dermatitis 01/2020 - 01/2018
2	Anemia 01/2020 - 06/2012
2	Thrombocytopenia (Thrombopenia) 11/2019 - 06/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 01/2016
2	Hypokalemia 01/2018 - 01/2015
2	Vomiting 02/2017 - 03/2014
2	Mucositis 02/2017 - 04/2012
2	Stomatitis 02/2017 - 02/2015
2	Hypertension (High Blood Pressure) 09/2016 - 05/2009
2	Hepatocellular Carcinoma (Hepatoma) 03/2016 - 10/2004
2	Prostatic Neoplasms (Prostate Cancer) 11/2014 - 06/2009
2	Proteinuria 05/2014 - 05/2009
1	Squamous Cell Carcinoma of Head and Neck 01/2021

Drug/Important Bio-Agent (IBA)

7	ErbB Receptors (EGF Receptor)IBA 04/2024 - 12/2017
7	Biomarkers (Surrogate Marker)IBA 11/2023 - 11/2014
6	Immune Checkpoint InhibitorsIBA 03/2021 - 01/2018
6	cemiplimabIBA 01/2021 - 01/2018
6	Monoclonal AntibodiesIBA 01/2021 - 05/2014
5	pembrolizumabIBA 01/2021 - 10/2015
4	Hormones (Hormone)IBA 04/2024 - 06/2009
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2022 - 05/2009
4	pegilodecakinIBA 01/2021 - 11/2018
3	belzutifanIBA 11/2023 - 01/2021
3	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 01/2018
3	Docetaxel (Taxotere)FDA Link 03/2022 - 01/2014
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2020 - 01/2015
3	Lipase (Acid Lipase)FDA Link 01/2020 - 03/2014
3	Midazolam (Versed)FDA LinkGeneric 01/2019 - 11/2014
3	Proteasome InhibitorsIBA 01/2019 - 10/2013
3	depatuxizumab mafodotinIBA 01/2019 - 12/2017
3	Phosphotransferases (Kinase)IBA 08/2018 - 10/2007
3	carfilzomibIBA 01/2017 - 10/2013
3	Phosphatidylinositols (Phosphatidylinositol)IBA 06/2015 - 04/2012
3	MK 2206IBA 02/2015 - 01/2014
3	Cisplatin (Platino)FDA LinkGeneric 12/2008 - 10/2003
2	binimetinibIBA 04/2024 - 02/2017
2	Transcription Factors (Transcription Factor)IBA 11/2023 - 01/2021
2	adagrasibIBA 10/2022 - 01/2020
2	glesatinibIBA 03/2022 - 01/2022
2	NivolumabIBA 01/2022 - 11/2019
2	Immunoglobulin G (IgG)IBA 01/2021 - 09/2017
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 06/2003
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 10/2007
2	Macrophage Colony-Stimulating FactorIBA 10/2020 - 10/2017
2	Cytochrome P-450 CYP3AIBA 01/2019 - 01/2018
2	ONX 0912IBA 01/2019 - 04/2016
2	Interleukin-10 (Interleukin 10)IBA 11/2018 - 10/2016
2	trametinibIBA 09/2016 - 01/2015
2	SurvivinIBA 01/2016 - 06/2012
2	sepantroniumIBA 01/2016 - 06/2012
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2016 - 10/2013
2	TOR Serine-Threonine KinasesIBA 06/2015 - 10/2012
2	XL765IBA 06/2015 - 05/2014
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2015 - 08/2014
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2015 - 01/2015
2	ridaforolimusIBA 11/2014 - 10/2012
2	ProdrugsIBA 11/2014 - 11/2008
2	vesencumabIBA 08/2014 - 05/2014
2	Bevacizumab (Avastin)FDA Link 05/2014 - 05/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2014 - 01/2014
2	Transaminases (Aminotransferases)IBA 06/2013 - 04/2012
2	Peptides (Polypeptides)IBA 06/2003 - 12/2002
1	Pemetrexed (MTA)FDA Link 11/2023
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 11/2023
1	Inducible T-Cell Co-Stimulator ProteinIBA 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	envafolimabIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Leucovorin (Folinic Acid)FDA Link 01/2021
1	GlucocorticoidsIBA 01/2021
1	MK-4166IBA 01/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021

Therapy/Procedure

16	Therapeutics 11/2023 - 10/2007
4	Radiotherapy 01/2021 - 03/2016
4	Drug Therapy (Chemotherapy) 03/2016 - 10/2003
2	Immunotherapy 03/2021 - 06/2003
1	Intravenous Administration 01/2021